CD44 and breast cancer: To obtain supporting data from patient tumours, we obtained CXCR4 transcript levels from Creighton et al. [28] where breast cancer stem cell-enriched populations (CD44+/CD24−) were sorted by flow cytometry and gene expression was analysed (Figure 2D).